CureVac N.V., a global biopharmaceutical company, has established CureVac RNA Printer GmbH, a fully-owned CureVac company designed to advance The RNA Printer.   The RNA Printer is CureVac’s solution for integrated and automated manufacturing of GMP-grade RNA vaccines and therapeutics. The new entity is designed as a platform and services company, providing a dedicated operational environment to further develop and establish The RNA Printer as a manufacturing end-to-end solution. This solution ...